BIO-TECHNE Corp
TECH- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000842023
No open-market purchases or sales by BIO-TECHNE Corp insiders were filed in the last 90 days; 597 institutions reported holding it in 13F filings for Q2 2026, worth $12.3B in total; 3 superinvestors hold it, including Maverick Capital and Weitz Investment Management.
Q1 2023 vs. Q4 2022
How the institutions holding BIO-TECHNE Corp changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 547 | 9 | 552 | +14 |
| Shares | 149.8M | 103.6K | 148.8M | −933.7K (−0.6%) |
| Value | $12.4B | $8.52M | $11.0B | −$1.37B (−11.0%) |
9 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (70)
Institutions that held BIO-TECHNE Corp at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (56)
Institutions that held BIO-TECHNE Corp at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (9)
Institutions that held BIO-TECHNE Corp at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Seeyond | 32,795 | $2.72M |
| Comerica Bank | 32,986 | $2.67M |
| Ascension Asset Management LLC | 17,752 | $1.47M |
| Icon Wealth Advisors, LLC | 10,433 | $864.7K |
| Allstate Investment Management Co | 7,860 | $651.4K |
| CoreCap Advisors, LLC | 1,500 | $124.3K |
| Heritage Wealth Management, LLC | 256 | $21.2K |
| Cornerstone Planning Group LLC | 20 | $1.62K |
| Glass Jacobson Investment Advisors llc | 10 | $829 |